Post marketing surveillance of pharmaceutical products by mobile laboratory in China
- At: 2007 FIP Congress in Beijing (China)
- Type: Presentation
- By: JIN, Shaohong (NICPBP, Beijing, China)
Since Counterfeit drug is a vile and directly impacts on human health post marketing surveillance is the main activities of China SFDA to combat this serious criminal offence. The counterfeits without active pharmaceutical ingredient (API), with wrong API, with incorrect quantities of API and with fake package were detected and seized in China.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.